4D Molecular Therapeutics, Inc. Common Stock

FDMTNASDAQ • USD
ThemeGenomics & Precision Med.›Gene Therapy & Gene Editing
11.03 USD
↗ 0.23 (2.13%)AT CLOSE (03:59 PM EDT)
11.04
↗ 0.01 (0.09%)
POST MARKET (AS OF 04:10 PM EDT)
Post Market
AS OF 04:10 PM EDT
11.04
↗ 0.01 (0.09%)
🟢Market: OPEN

Shares of 4D Molecular Therapeutics, Inc. Common Stock (FDMT) are trading at $11.04. Both sides of the analysis point lower: technicals flash "Strong Sell" and fundamentals confirm with a "Sell" reading. Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 1/9, negative Return on Equity and a bullish Golden Cross on the moving averages. Valuation metrics place FDMT at a fair price relative to peers.

Technical & fundamental data as of Oct 23, 2026.

Open?$10.74
High?$11.29
Low?$10.62
Prev. Close?$10.80
Volume?1.1M
Avg. Volume?1.1M
VWAP?$11.02
Rel. Volume?1.01x
Bid / Ask
Bid?$9.51 × 100
Ask?$13.24 × 100
Spread?$3.73
Midpoint?$11.38
Valuation & Ratios
Market Cap?596.6M
Shares Out?55.2M
Float?53.3M
Float %?96.6%
P/E Ratio?N/A
P/B Ratio?1.46
EPS?-$3.24
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
4D Molecular Therapeutics Inc is biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients. Companies focus is on advancing 4D-150 for wet age-related macular degeneration (wet AMD) and diabetic macular edema (DME) through late-stage studies. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-710 and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector).
Themes
Healthcare - Genomics & Precision Medicine›Gene Therapy & Gene EditingBiotech - Drug Development›Clinical-Stage Platforms
Employees
196
Market Cap
596.6M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
www.4dmoleculartherapeutics.com
Listed
2020-12-11
Address
5858 HORTON STREET #455
EMERYVILLE, CA 94608
Phone: (510) 505-2680
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-1/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
6
Z-Score?
20
Momentum?
48
Short Sent.?
50
Piotroski F-Score?1/9Weak
Altman Z-Score?1.46Distress
Confidence?65%Moderate
Full Fundamental Analysis →
Short InterestSqueeze Risk
Short % of Float?21.07%Squeeze Risk
Short Interest?11.2M
Days to Cover?9.3
Free Float53.3M
Avg Daily Volume1.2M
Settlement Date2026-09-30
Financial Health
Current Ratio?8.03Strong
Quick Ratio?8.03Strong
Cash Ratio?1.48Strong
Debt/Equity?0.05Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
83/100
P/E?
N/A▾
P/B?
Peers
100
S&P
88
1.46CHEAP▾
P/S?
Peers
100
S&P
19
6.48FAIR▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-2.8CHEAP▾
EV/Sales?
Peers
100
S&P
28
5.93FAIR▾
Returns & Efficiency
ROE?
S&P
3
-44.0%WEAK▾
ROA?
S&P
3
-36.4%WEAK▾
Cash Flow & Enterprise
FCF?$-156177000
Enterprise Value?$545.9M
Fundamentals ratios updated end of day
MarketsMoversWatchlist